BioCentury
ARTICLE | Management Tracks

Longtime Roche CEO Humer named Kallyope chairman

Plus: Imara vet Gray becomes Carmot’s COO, CFO, and updates from Nucleix, T-CURX, Zephyr, CN Bio, Kronos

June 6, 2023 10:02 PM UTC

Franz Humer became chairman of  Kallyope Inc., which is developing small molecules for metabolic, gastrointestinal and neurological diseases. Humer was CEO of Roche (SIX:ROG; OTCQX:RHHBY) in 1998-2001, chairman and CEO during 2001-08 and chairman 2008-14. 

Metabolic disease company Carmot Therapeutics Inc. hired Michael Gray as COO and CFO. Gray held the same titles at Imara Inc. (NASDAQ:IMRA), where he helped lead the company through its 2020 IPO...